These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30416390)

  • 1. Inhibition of Estrogen Signaling Reduces the Incidence of
    Baek HJ; Kim SE; Choi EK; Kim JK; Shin DH; Park EJ; Kim TH; Kim JY; Kim KG; Deng CX; Kim SS
    Int J Biol Sci; 2018; 14(12):1755-1768. PubMed ID: 30416390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen promotes estrogen receptor negative BRCA1-deficient tumor initiation and progression.
    Wang C; Bai F; Zhang LH; Scott A; Li E; Pei XH
    Breast Cancer Res; 2018 Jul; 20(1):74. PubMed ID: 29996906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRCA1-associated mammary tumorigenesis is dependent on estrogen rather than progesterone signaling.
    van de Ven M; Liu X; van der Burg E; Klarenbeek S; Alexi X; Zwart W; Dijcks F; Bouwman P; Jonkers J
    J Pathol; 2018 Sep; 246(1):41-53. PubMed ID: 29877575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of estrogen signaling pathways collaborates with loss of Brca1 to promote development of ERalpha-negative and ERalpha-positive mammary preneoplasia and cancer.
    Jones LP; Tilli MT; Assefnia S; Torre K; Halama ED; Parrish A; Rosen EM; Furth PA
    Oncogene; 2008 Jan; 27(6):794-802. PubMed ID: 17653086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRCA1 ensures genome integrity by eliminating estrogen-induced pathological topoisomerase II-DNA complexes.
    Sasanuma H; Tsuda M; Morimoto S; Saha LK; Rahman MM; Kiyooka Y; Fujiike H; Cherniack AD; Itou J; Callen Moreu E; Toi M; Nakada S; Tanaka H; Tsutsui K; Yamada S; Nussenzweig A; Takeda S
    Proc Natl Acad Sci U S A; 2018 Nov; 115(45):E10642-E10651. PubMed ID: 30352856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRCA1 and estrogen/estrogen receptor in breast cancer: where they interact?
    Wang L; Di LJ
    Int J Biol Sci; 2014; 10(5):566-75. PubMed ID: 24910535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The breast cancer susceptibility gene BRCA1 regulates progesterone receptor signaling in mammary epithelial cells.
    Ma Y; Katiyar P; Jones LP; Fan S; Zhang Y; Furth PA; Rosen EM
    Mol Endocrinol; 2006 Jan; 20(1):14-34. PubMed ID: 16109739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent Activation of NF-κB in BRCA1-Deficient Mammary Progenitors Drives Aberrant Proliferation and Accumulation of DNA Damage.
    Sau A; Lau R; Cabrita MA; Nolan E; Crooks PA; Visvader JE; Pratt MA
    Cell Stem Cell; 2016 Jul; 19(1):52-65. PubMed ID: 27292187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of AKT suppresses the initiation and progression of
    Baek HJ; Kim SE; Kim JK; Shin DH; Kim TH; Kim KG; Deng CX; Kim SS
    Int J Biol Sci; 2018; 14(13):1769-1781. PubMed ID: 30443181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen metabolites and breast cancer.
    Santen RJ; Yue W; Wang JP
    Steroids; 2015 Jul; 99(Pt A):61-6. PubMed ID: 25168343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deregulated estrogen receptor signaling and DNA damage response in breast tumorigenesis.
    Rajan A; Nadhan R; Latha NR; Krishnan N; Warrier AV; Srinivas P
    Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188482. PubMed ID: 33260050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhodiola crenulata induces an early estrogenic response and reduces proliferation and tumorsphere formation over time in MCF7 breast cancer cells.
    Bassa LM; Jacobs C; Gregory K; Henchey E; Ser-Dolansky J; Schneider SS
    Phytomedicine; 2016 Jan; 23(1):87-94. PubMed ID: 26850689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells.
    Kawai H; Li H; Chun P; Avraham S; Avraham HK
    Oncogene; 2002 Oct; 21(50):7730-9. PubMed ID: 12400015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of ABCG2 shortens latency of BRCA1-deficient mammary tumors and this is not affected by genistein or resveratrol.
    Zander SA; Kersbergen A; Sol W; Gonggrijp M; van de Wetering K; Jonkers J; Borst P; Rottenberg S
    Cancer Prev Res (Phila); 2012 Aug; 5(8):1053-60. PubMed ID: 22767648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer.
    Regan JL; Kendrick H; Magnay FA; Vafaizadeh V; Groner B; Smalley MJ
    Oncogene; 2012 Feb; 31(7):869-83. PubMed ID: 21765473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha.
    Bocchinfuso WP; Hively WP; Couse JF; Varmus HE; Korach KS
    Cancer Res; 1999 Apr; 59(8):1869-76. PubMed ID: 10213494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth factor signaling pathways modulate BRCA1 repression of estrogen receptor-alpha activity.
    Ma Y; Hu C; Riegel AT; Fan S; Rosen EM
    Mol Endocrinol; 2007 Aug; 21(8):1905-23. PubMed ID: 17505062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolactin drives estrogen receptor-alpha-dependent ductal expansion and synergizes with transforming growth factor-alpha to induce mammary tumors in males.
    Arendt LM; Schuler LA
    Am J Pathol; 2008 Jan; 172(1):194-202. PubMed ID: 18156207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer.
    Liu X; Holstege H; van der Gulden H; Treur-Mulder M; Zevenhoven J; Velds A; Kerkhoven RM; van Vliet MH; Wessels LF; Peterse JL; Berns A; Jonkers J
    Proc Natl Acad Sci U S A; 2007 Jul; 104(29):12111-6. PubMed ID: 17626182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis.
    Yue W; Santen RJ; Wang JP; Li Y; Verderame MF; Bocchinfuso WP; Korach KS; Devanesan P; Todorovic R; Rogan EG; Cavalieri EL
    J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):477-86. PubMed ID: 14623547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.